Near-term analysis of 2019 Novel Coronavirus (2019-nCoV)
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- HHSF223201510104C_P00004
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HHSF223201510104C Federal contract award
- Awardee
- Public Health England
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- GBR
Notice details come from SAM.gov. Updated .
Notice text
Sole source modification to existing contract number HHSF223201510104C with Public Health England (PHE) to leverage existing laboratory capabilities currently used for Ebola studies to complete several urgent objectives to support the public health response to the 2019 novel Coronavirus (2019-nCoV). Objectives include the following:
1.) Construct pseudoviruses for 2019-nCoV;
2.) Produce standardized characterized strains, prepare stocks of for further distribution, and provide standardized full-length clone technology for 2019-nCoV;
3.) Develop rapid and validated methods for sequencing 2019-nCoV, and;
4.) Conduct comparative Ebola analysis utilizing the FANG assay.
Awarded contract HHSF223201510104C to unknown vendor for unknown amount on 2020-03-02.
Files
| File | Type | Posted |
|---|---|---|
| JA_02212020_HHSF223201510104C_V.2TMsgnd_Redacted.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity